Table II.
Effects of tamoxifen on various life-threatening and severe events, expressed as relative risks compared to placebo.*
| Type of event | Relative risk | 95% Confidence interval | 
|---|---|---|
| Life-threatening events | ||
| Invasive breast cancer | 0.51 | 0.39 to 0.66 | 
| Hip fracture | 0.55 | 0.25 to 1.15 | 
| Endometrial cancer | ||
| All women | 2.53 | 1.35 to 4.97 | 
| Women ≥50 years old | 4.01 | 1.70–10.90 | 
| Stroke | 1.59 | 0.93 to 2.77 | 
| Pulmonary embolism | 3.01 | 1.15 to 9.27 | 
| Severe events | ||
| In situ breast cancer | 0.50 | 0.33 to 0.77 | 
| Deep vein thrombosis | 1.60 | 0.91 to 2.86 | 
Data from [39].